Main 3-Year Outcomes of CASTLE-HTx

31 August 2025 (11:45 - 12:00)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Philipp Sommer

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

3 More presentations in this session

Presentation thumbnail

RELAXIN-LA in worsening HFpEF

Professor J. Testani (New Haven, US)

Presentation thumbnail

Effect of finerenone on the plasma proteome: a FINEARTS-HF analysis

Doctor M. Berger (Wuppertal, DE)

Presentation thumbnail

MRA response score in HFrEF

Professor N. Girerd (Nancy, FR)

Access the full session

Session thumbnail

Late-Breaking Clinical Science: therapeutic innovations in heart failure

The Event

Event poster

ESC Congress 2025

31 August 2025 11:45 CET

You may be interested in

Congress Presentation

Catheter ablation in end-stage heart failure with atrial fibrillation: two-year follow-up of the CASTLE-HTx trial

Congress Presentation

Prognosis of patients in end-stage heart failure with atrial fibrillation treated with ablation - Insights from Castle HTX

Congress Presentation

Ask the Trialist - CASTLE-HTx

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources